Role of radiation in oligo-progression in EGFR mutated metastatic non small cell lung cancer

被引：0
|
作者：
Rathee, N. [1 ]
Arunsingh, M. [1 ]
Bhattacharyya, T. [1 ]
Majumder, P. [1 ]
Chowdhury, O. [1 ]
Shah, S. [1 ]
机构：
[1] Tata Med Ctr, Kolkata, India
来源：
CLINICAL ONCOLOGY | 2024年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HAB035
引用
收藏
页码：E367 / E367
页数：1
相关论文
共 50 条
  • [31] Clinical benefit of EGFR-TKIs plus radiotherapy for treating EGFR-mutated metastatic non-small cell lung cancer.
    Wang, Ran Lin
    Li, Tao
    Lv, Jiahua
    Sun, Chang
    Shi, Qiuling
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
    Shepherd, Annemarie F.
    Preeshagul, Isabel R.
    Shaverdian, Narek
    Wu, Abraham J.
    Gelblum, Daphna Y.
    Gomez, Daniel R.
    Rimner, Andreas
    Simone, Charles B., II
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [34] NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER
    Ianza, A.
    Dicorato, A.
    Guglielmi, A.
    Orlando, V.
    Furlanis, G.
    Curro, F.
    CHEST, 2022, 161 (06) : 333A - 333A
  • [35] Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
    Soria, J. -C.
    Ohe, Y.
    Vansteenkiste, J.
    Reungwetwattana, T.
    Chewaskulyong, B.
    Lee, K. H.
    Dechaphunkul, A.
    Imamura, F.
    Nogami, N.
    Kurata, T.
    Okamoto, I.
    Zhou, C.
    Cho, B. C.
    Cheng, Y.
    Cho, E. K.
    Voon, P. J.
    Planchard, D.
    Su, W. -C.
    Gray, J. E.
    Lee, S. -M.
    Hodge, R.
    Marotti, M.
    Rukazenkov, Y.
    Ramalingam, S. S.
    Boyer, Michael
    Lee, Chee
    Hughes, Brett
    O'Byrne, Kenneth
    Briggs, Peter
    Milward, Michael
    John, Thomas
    Demedts, Ingel
    Vansteenkiste, Johan
    Bustin, Frederique
    Barrios, Carlos Henrique
    Timcheva, Constanta
    Butts, Charles
    Goss, Glenwood
    Juergens, Rosalyn
    Leighl, Natasha
    Cheng, Susanna
    Burkes, Ronald
    Zhou, Caicun
    Zhang, Helong
    Shu, Yongqian
    Cheng, Ying
    Zhou, Qing
    Li, Wei
    Feng, Guosheng
    He, Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 113 - 125
  • [36] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Leonetti, Alessandro
    Sharma, Sugandhi
    Minari, Roberta
    Perego, Paola
    Giovannetti, Elisa
    Tiseo, Marcello
    BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 725 - 737
  • [37] Selectivity profile of afatinib for EGFR-mutated non-small-cell lung cancer
    Wang, Debby D.
    Lee, Victor H. F.
    Zhu, Guangyu
    Zou, Bin
    Ma, Lichun
    Yan, Hong
    MOLECULAR BIOSYSTEMS, 2016, 12 (05) : 1552 - 1563
  • [38] Critical points in the management of EGFR-mutated non-small cell lung cancer
    Casaluce, Francesca
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 1748 - 1752
  • [39] Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer
    Cardona, A.
    Arrieta, O.
    Rojas, L.
    Zatarain-Barron, Z.
    Ricaurte, L.
    Ruiz-Patino, A.
    Martin, C.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S871 - S871
  • [40] Prognosis of uncommon metastasis in non-small-cell lung cancer patients with mutated EGFR
    Yoshimura, Akihiro
    Tsuji, Taisuke
    Takumi, Chieko
    Hamashima, Ryosuke
    Shiotsu, Shinsuke
    Yuba, Tatsuya
    Hiraoka, Noriya
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345